Anti-Human CD354/TREM1 Antibody (SAA2019)

Anti-Human CD354/TREM1 Antibody (SAA2019)

  • Catalog number: RA12805
  • Availability: In Stock
  • $196.00

  • Ex Tax: $196.00


Available Options

Qty

Description: Anti-Human CD354/TREM1 Antibody (SAA2019) [SAA2019] (RA12805) is a human monoclonal antibody detecting TREM1 in ELISA, WB. Suitable for Human.
Host species: Human
Isotype: IgG1, kappa
Species reactivity: Human
Form: Liquid
Storage buffer: 0.01M PBS, pH 7.4.
Concentration: 1 mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: ELISA, WB
Target: TREM1, Triggering receptor expressed on monocytes 1, Triggering receptor expressed on myeloid cells 1, TREM-1, CD354
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: Please contact with the lab for this information.
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names:
Background: Triggering receptor expressed on myeloid cells 1 (CD354/TREM1) is a ~26 kDa protein. Cell surface receptor that plays important roles in innate and adaptive immunity by amplifying inflammatory responses. Upon activation by various ligands such as PGLYRP1, HMGB1 or HSP70, multimerizes and forms a complex with transmembrane adapter TYROBP/DAP12. In turn, initiates a SYK-mediated cascade of tyrosine phosphorylation, activating multiple downstream mediators such as BTK, MAPK1, MAPK3 or phospholipase C-gamma. This cascade promotes the neutrophil- and macrophage-mediated release of pro-inflammatory cytokines and/or chemokines, as well as their migration and thereby amplifies inflammatory responses that are triggered by bacterial and fungal infections. By also promoting the amplification of inflammatory signals that are initially triggered by Toll-like receptor (TLR) and NOD-like receptor engagement, plays a major role in the pathophysiology of acute and chronic inflammatory diseases of different etiologies including septic shock and atherosclerosis.
References:
1. Bouchon, A. et al. (2000) Journal of immunology (Baltimore, Md. : 1950) 164, 4991-5. PMID: 10799849
2. Arts, RJ. et al. (2011) European cytokine network 22, 11-4. PMID: 21393102
3. El Mezayen, R. et al. (2007) Immunology letters 111, 36-44. PMID: 17568691
4. Read, CB. et al. (2015) Journal of immunology (Baltimore, Md. : 1950) 194, 1417-21. PMID: 25595774
5. Carrasco, K. et al. (2019) Cellular & molecular immunology 16, 460-472. PMID: 29568119
6. Radaev, S. et al. (2003) Structure (London, England : 1993) 11, 1527-35. PMID: 14656437
7. Ormsby, T. et al. (2011) Blood 118, 936-45. PMID: 21659545
8. Fortin, CF. et al. (2007) International immunology 19, 41-50. PMID: 17098818
9. Bouchon, A. et al. (2001) Nature 410, 1103-7. PMID: 11323674
Note: For research use only.

Images

  • SDS-PAGE for Anti-Human CD354/TREM1 Antibody (SAA2019)
    SDS-PAGE

    SDS-PAGE for Anti-Human CD354/TREM1 Antibody (SAA2019).

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good